Low Levels of p27 in Association with Deregulated p53-pRb Protein Status Enhance Tumor Proliferation and Chromosomal Instability in Non-Small Cell Lung Carcinomas

Molecular Medicine

Volumn 7, Issue 6, 2001, Pages 418-429

  Tsoli, Efthymia ^a   Gorgoulis, Vassilis G ^a,e   Zacharatos, Panayotis ^a   Kotsinas, Athanassios ^a   Mariatos, George ^a   Kastrinakis, Nikolaos G ^a   Kokotas, Stavros ^a   Kanavaros, Panayotis ^b   Asimacopoulos, Panayotis ^a   Bramis, John ^c   Kletsas, Dimitris ^d   Papavassiliou, Athanasios G ^f   Kittas, Christos ^a  

^a UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

^b UNIVERSITY OF THESSALY   (Greece)

^c UNIVERSITY OF ATHENS   (Greece)

^d INSTITUTE OF NANOSCIENCE AND NANOTECHNOLOGY   (Greece)

^e Lamprini Ano Patisia   (Greece)

^f NONE

Author keywords

[No Author keywords available]

Indexed keywords

CELL CYCLE PROTEIN; CYCLIN DEPENDENT KINASE; CYCLIN DEPENDENT KINASE INHIBITOR 1B; ENZYME INHIBITOR; PROTEIN P53; RETINOBLASTOMA PROTEIN; TUMOR SUPPRESSOR PROTEIN;

ARTICLE; DRUG ANTAGONISM; GENETICS; HUMAN; IMMUNOHISTOCHEMISTRY; LUNG NON SMALL CELL CANCER; LUNG TUMOR; METABOLISM; NICK END LABELING; ONCOGENE RAS; PATHOLOGY; PATHOPHYSIOLOGY; PLOIDY;

CARCINOMA, NON-SMALL-CELL LUNG; CELL CYCLE PROTEINS; CYCLIN-DEPENDENT KINASE INHIBITOR P27; CYCLIN-DEPENDENT KINASES; ENZYME INHIBITORS; GENES, RAS; HUMANS; IMMUNOHISTOCHEMISTRY; IN SITU NICK-END LABELING; LUNG NEOPLASMS; PLOIDIES; RETINOBLASTOMA PROTEIN; TUMOR SUPPRESSOR PROTEIN P53; TUMOR SUPPRESSOR PROTEINS;

EID: 0035376143     PISSN: 10761551     EISSN: None     Source Type: Journal    
DOI: 10.1007/bf03402188     Document Type: Article

References (48)

1. Kip1: A multifunctional cyclin-dependent kinase inhibitor with prognostic significance in human cancers. Am. J. Pathol. 154: 313-323.
2. Alessandrini A, Chiaur DS, Pagano M. (1997) Regulation of the cyclin-dependent kinase inhibitor p27 by degradation and phosphorylation. Leukemia 11: 342-345.
3. Kip1 chromosomal mapping to 12p 12-12p13.1 and absence of mutations in human tumors. Cancer Res. 55: 1211-1214.
4. Kip1. Gen. Dev. 11: 1464-1478.
5. KiP1 blocks cyclin E-dependent transactivation of cyclin A gene expression. Mol Cell Biol. 17: 407-415.
6. Stegmaier K, Takeuchi S, Golub TR, Bohlander SK, Bartram CR, Koeffler HP. (1996) Mutational analysis of the candidate tumor suppressor genes TEL and KIP1 in childhood acute lymphoblastic leukemia. Cancer Res.56: 1413-1417.
7. Kip1 downregulation passage through the restriction point, and entry into S phase in growth factor-stimulated NIH 3T3 fibroblasts. Mol. Cell Biol. 12: 5348-5358.
8. Esposito V, Baldi A, De Luca A, et al. (1997) Prognostic role of the cyclin-dependent kinase inhibitor p27 in non-small cell lung cancer. Cancer Res. 57: 3381-3385.
9. Kip1 in human lung cancers: Differential changes in small cell and non-small cell carcinomas. Cancer Res. 58: 1042-1047.
10. Ishihara S, Minato K, Hoshino H, Saito R, Hara F, Nakajima T, Mori M. (1999) The cyclin-dependent kinase inhibitor p27 as a prognostic factor in advanced non-small cell lung cancer: its immunohistochemical evaluation using biopsy specimens. Lung Cancer 26: 187-194.
11. Shoji M, Dobashi Y, Morinaga S, Jiang S-X, Kameya T. (1999) Tumor extension and cell proliferation in adenocarcinomas of the lung. Am. J. Pathol. 154: 909-918.
12. Kip1 in non-small cell lung carcinoma: A prognostic factor independent of Ras. Cancer Res. 59: 684-688.
13. Kip1 and cyclin-dependent kinase 2 in the proliferation of non-small cell lung cancer. Am. J. Pathol. 153: 505-513.
14. Sanchez-Beato M, Camacho FI, Martinez-Montero JC, et al. (1999) Anomalous high p27/KIP1 expression in a subset of aggressive B-cell lymphomas is associated with cyclin D3 overexpression. p27/KIP1- cyclin D3 colocalization in tumor cells. Blood 94: 765-772.
15. Prives C, Hall PA. (1999) The p53 pathway. J. Pathol. 187: 112-126.
16. Mountain C. (1997) Revisions in the international system for staging lung cancer. Chest 111: 1710.
17. Mariatos G, Gorgoulis VG, Zacharatos P, et al. (2000) Expression of p16/NK4A and alterations of the 9p21-23 chromosome region in non-small-cell lung carcinomas: relationship with tumor growth parameters and ploidy status. Int. J. Cancer 89: 133-141.
18. Gorgoulis VG, Zacharatos P, Kotsinas A, et al. (1998) Alterations of the p16-pRb pathway and the chromosome locus 9p21-22 in non-small-cell lung carcinomas: relationship with p53 and MDM2 protein expression. Am. J. Pathol. 153: 1749-1765.
19. Gorgoulis VG, Zacharatos P, Kotsinas A, et al. (2000) Altered expression of the cell cycle regulatory molecules pRb, p53 and MDM2 exert a synergetic effect on tumor growth and chromosomal instability in non-small cell lung carcinomas (NSCLCs). Mol. Med. 6: 208-237.
20. Sambrook J, Fritsch EF, Maniatis T. (1989) Molecular cloning: a laboratory manual. New York: Cold Spring Harbor Laboratory Press.
21. Kotsinas A, Spandidos DA, Romanowski P, Wyllie AH. (1993) Relative expression of wild-type and activated Kiras2 oncogene in colorectal carcinomas. Int. J. Oncol. 3: 841-845.
22. Gavrieli Y, Sherman Y, Ben-Sasson S. (1992) Identification of programmed cell death in situ via specific labelling of nuclear DNA fragmentation. J. Cell Biol. 119: 493-501.
23. Hirano T, Franzen B, Kato H, Ebihara Y, Auer G. (1994) Genesis of squamous-cell lung carcinoma. Sequential changes of proliferation, DNA ploidy, and p53 expression. Am. J. Pathol. 144: 296-302.
24. Gerdes J, Lemke H, Baisch H, Wacker HH, Schwab U, Stein H. (1984) Cell-cycle analysis of a cell proliferation-associated human nuclear antigen defined by the monoclonal antibody Ki-67. J. Immunol. 133: 1710-1715.
25. Sousek T, Yeung RS, Hengstschlager M. (1998) Inactivation of the cyclin-dependent kinase inhibitor p27 upon koss of the tuberous sclerosis complex gene-2. Proc. Natl Acad. Sci. U.S.A. 95: 15653-15658.
26. Kip1 is investigated by Jab1. Nature (Lond.) 398: 160-165.
27. Fero ML, Randel E, Gurley KE, Roberts JM, Kemp CJ. (1998) The murine gene p27 kip1 is haplo-insufficient for tumour suppression. Nature 396: 177-180.
28. Kawamata N, Morosetti R, Miller CW, et al. (1995) Molecular analysis of the cyclin-dependent kinase inhibitor gene p27/kip1 in human malignancies. Cancer Res. 55: 2266-2269.
29. Qian X, Jin L, Kulig E, Lloyd RV. (1998) DNA methylation regulates p27 expression in rodent pituitary cell lines. Am. J. Pathol. 153: 1475-1482.
30. Hengst L, Reed S. (1996) Translational control of p27 kip1 accumulation during the cell cycle. Science 271: 1861-1864.
31. Kip1 mRNA is a mechanism contributing to accumulation during growth arrest. J. Biol. Chem.272: 7093-7098.
32. Kip1 expression in thyroid carcinoma. Mod. Pathol. 11: 735-739.
33. Masciullo V, Sgambato A, Pacilio C, et al. (1999) Frequent loss of expression of the cyclin-dependent kinase inhibitor p27 in epithelial ovarian cancer. Cancer Res. 59: 3790-3794.
34. Kip1 expression in endocrine and other tumors. Am. J. Pathol. 150: 401-407.
35. Kip1 expression in colorectal cancer: a clinicopathological characterization. J Pathol 188: 18-23.
36. Kip1, correlates with histopathological grade of non-Hodgkin's lymphoma. Jpn. J. Cancer Res. 90: 1262-1269.
37. Sekido Y, Fong KM, Minna JD. (1998) Progress in understanding the molecular pathogenesis of human lung cancer. Biochim. Biophys. Acta 1378: F21-F59.
38. Sanchez-Beato M, Saez AI, Martinez-Montero JC, et al. (1997) Cyclin-dependent kinase inhibitor p27(KIP1) in lymphoid tissue: p27(KIP1) expression is inversely proportional to the proliferative index. Am. J. Pathol. 151: 151-160.
39. Jordan RCK, Bradley G, Slingerland J. (1998) Reduced levels of the cell cycle inhibitor p27 Kip1 in epithelial dysplasia and carcinoma of the oral cavity. Am. J Pathol. 152: 585-590.
40. Tan P, Cady B, Wanner M, et al. (1997) The cell cycle inhibitor p27 is an independent prognostic marker in small (t-la,t-b) invasive breast carcinomas. Cancer Res. 57: 1259-1263.
41. Kip1 protein expression and spontaneous apoptosis in patients with colorectal adenocarcinomas. Oncology 58: 45-51.
42. Classon M, Salama S, Gorka C, Mulloy R, Braun P, Harlow E. (2000) Combinatorial roles for pRb, p107 and p130 in E2F-mediated cell cycle control. Proc. Natl. Acad. Sci. U.S.A. 97: 10820-10825.
43. El Deiry WS, Tokino T, Velculescu VE, et al. (1993) WAF1, a potential mediator of p53 tumor suppression. Cell 75: 817-825.
44. Kip1 induces cell cycle arrest and loss of cyclin-Cdk activity in human breast cancer cells Oncogene 14: 2283-2289.
45. Katayose Y, Kim M, Rakkar ANS, Li Z, Cowan KH, Seth P. (1997) Promoting apoptosis: a novel activity associated with the cyclin-dependent kinase inhibitor p27. Cancer Res. 57: 5441-5445.
46. Kip1 safeguards against inflammatory injury. Nat. Med. 4: 575-580.
47. Kip1 mediates apoptosis in endothelial cells through activation of Cdk2: role of a caspase cascade. Mol. Cell. 1: 553-563.
48. Paulovich AG, Toczyski DP, Hartwell LH. (1997) When checkpoints fail. Cell 88: 315-321.